Objectives: This study aims to evaluate the reliability, factor structure, and validity of the Turkish version of the Pain Disability Index (PDI) in patients with chronic pain.
Pain persisting for more than six months is referred to as "chronic pain." Chronic pain tends to continue despite treatment and not only affects the age at which people can continue to work, but also increases morbidity and hospital admission, and reduces participation in activities and quality of life. [1] [2] [3] There have been studies showing that pain, especially chronic pain, may cause disabilities to various degrees. 4, 5 Disability is important for measuring disease burden and evaluating the effectiveness of health interventions. Pain-related disability is how well an individual is able to function in general areas of life and is poorly related to pathophysiology. It is much better correlated with the extent of pain and psychological distress in rheumatic patients with chronic pain. However, defining and measuring disability have been challenging. [6] [7] [8] [9] There are various symptoms causing disability in rheumatic diseases such as joint movement restriction, fatigue, weakness, pain, neurological symptoms, and other organ/system involvement. Most of the scales for assessing disability in rheumatic diseases focus on the entire disease rather than one symptom, whereas knowing which symptoms are responsible for the disability is important for clinical management. In Turkey, there are many scales assessing disability and quality of life; however, there is no adequate instrument for measuring pain-related disability in rheumatic diseases. The Pain Disability Index (PDI) is a simple and rapid instrument for measuring the impact the pain has on the ability of a person to participate in basic life activities. 10 Therefore, in this study, we aimed to evaluate the reliability, factor structure, and validity of the Turkish version of the PDI in patients with chronic pain.
PATIENTS AND METHODS
The study included 212 patients (34 males, 178 females; mean age 47.9±10.3 years; range 19 to 65 years) with rheumatologic diseases and chronic pain symptoms. 11 The inclusion criteria were as follows; 18 to 65 years of age, outpatient follow-up for at least one year in rheumatology clinic, and pain continuing for the past six months comprising at least three of the following properties; (i) affecting one or more joints or body region, (ii) worsening with motion or touch, (iii) symptomatically improving after mild exercise, but worsening after heavy exercise, (iv) symptomatically worsening in response to climatic factors such as air pressure and humidity, (v) symptomatically improving in response to warming of the affected regions, and (vi) well-localization. The exclusion criteria were as follows; other medical conditions that might cause chronic pain, patients with severe diseases requiring care or with severe mental illnesses. The study protocol was approved by the Yildirim Beyazit University Ethics Committee. A written informed consent was obtained from each patient. The study was conducted in accordance with the principles of the Declaration of Helsinki.
Developed by Raymond C. Tait, the PDI is a selfreporting questionnaire that measures the degree to which pain presently interferes with living in the following seven areas; family and/or home responsibilities, leisure activity, social activity, occupation, sexual behavior, self-care, and lifesupport activities. To complete the PDI, the respondent uses an 11-point scale ranging from 0 (no disability) to 10 (total disability). A total score is obtained by summing the responses to the seven items. 10 The PDI was translated from its original English version into Turkish according to a standardized procedure described previously. 12, 13 In the first step, PDI was translated into Turkish and this translations were combined into final version by two native Turkish speakers. In second step, final Turkish version of the questionnaire was translated back into English by other researchers. In third step, all of the researchers of the study evaluated the entire Turkish PDI version and approved the pre-final version. Ten patients with a rheumatologic disease performed the pre-final version and all of them were asked if they were able to understand and interpret the questions clearly and correctly. Their answers were discussed among the study researchers and the Turkish version was finalized (see the appendix in page 271).
Pain was the main factor causing disability in our study. The symptoms other than pain in rheumatic diseases were not considered on the PDI. Questions of PDI evaluate the disability caused by pain. Therefore, we included rheumatic patients with chronic pain instead of just one rheumatic disease. Also, we created the study sample taking into account the epidemiology of rheumatic diseases such as sex and prevalence.
Patients were given written instructions to respond to the PDI, a visual analog scale (VAS) for pain severity, and the Brief Disability Questionnaire (BDQ). Patients also answered questions that screened for sociodemographic characteristics, current medical and/or psychiatric problems, total duration of chronic pain, and analgesic use.
The VAS was used to measure pain severity. VAS is a common instrument used worldwide with tested validity and reliability.
14 Patients with chronic pain were instructed to make an assessment by considering their ongoing pain over the last week.
The BDQ was developed based on the disability-related questions of the General Health Survey Short Form in order to evaluate physical and social disability. 15 The Turkish reliability and validity of the BDQ were also performed. 16 
Statistical analysis
The sampling adequacy was determined using tests including Kaiser-Meyer-Olkin and Barlett's test of sphericity. An exploratory factor analysis (principal component analysis with varimax rotation, and the number of factor was determined according to an eigenvalue >1 and/or to explain more than 10% of the total variance) and a confirmatory factor analysis (maximum likelihood estimation) were performed for the PDI. The goodness-of-fit was evaluated using four criteria; the goodness-of-fit index, comparative fit index, the root-mean-square error of approximation, and the ratio of the chi-squared value to its degrees of freedom (c 2 /df). To determine the convergent validity of the PDI, the relations between the VAS and the BDQ were examined using the Pearson correlation technique. Cronbach's alpha coefficient, test-retest and the split-half method were also used for testing the reliability of the entire PDI scale. Floor and ceiling effects were examined by considering the number of individuals that obtained the lowest (0) or highest (70) scores possible and were assumed to be present if more than 15% of the participants achieved the highest or lowest score. 17 
RESULTS
Demographic and clinical characteristics of the participants are shown in Table 1 . The most common diagnoses were rheumatoid arthritis (41.9%) and seronegative spondyloarthropathies (30.6). Ceiling and floor effects were not detected (Table 1, Figure 1 ).
Cronbach's alpha was used for internal consistency analysis of the PDI and determined to be r=0.86 for the entire test. For the two factors, Cronbach's alpha values were 0.82 (discretionary activity) and 0.80 (obligatory activity). None of the Cronbach's alpha values improved when any item was deleted. The split-half reliability of the scale (Spearman-Brown correction) was 0.78. The testretest method was used to determine the reliability of the scale, and the PDI was repeated for this purpose about one month after the first test on 30 randomized patients from among the original sample of participants. There were no significant differences in sex ratio, education level, mean age, and BDQ and VAS total scores between the random subgroup and the study sample. We found that the test-retest Pearson correlation coefficient of the scale's total score was 0.75 (p<0.001 and bootstrapped 95% confidence interval of 0.511-0.878). The inter-item and item total and subscale correlations are listed in Table 2 .
The Barlett's test of sphericity indicated that the PDI items were interdependent: Chi-square (21)=681.2, p<0.001. The Kaiser-MeyerOlkin measure of sample adequacy was 0.862. Exploratory factor analysis provided a two-factor Convergent validity was assessed as a result of an examination of the relationships among PDI, VAS, and BDQ total scores using correlation analysis. According to this analysis, there was a significant correlation between PDI and VAS (r=0.539 and p<0.001) and PDI and BDQ (r=0.309 and p<0.001) ( Table 2 ). Summary of our results with the other adaptation studies are shown in Table 3 .
DISCUSSION
It is important to properly assess the level of disability according to the factors causing the disability. Therefore, in this study, the psychometric properties of the Turkish version of the PDI that measures the level of pain related disability were examined in patients with chronic pain. Our study revealed a successful translation of the PDI into Turkish. The translation was shown to have good reliability (Cronbach's alpha=0.86, test-retest correlation=0.75). In the original scale development study, Tait et al. 18 found the internal consistency of the scale to be r=0.86. The test-retest reliability (r=0.91) within a week of the PDI administration was studied by Gronblad et al. 19 In various studies, Cronbach's alpha of the PDI was found to be between 0.79 and 0.89. 10, [19] [20] [21] [22] [23] In our study, factor analysis yielded a two-factor solution that accounted for 69.8% of the total variance. The first factor explained 57.4% of the total variance, while the second factor explained 12.3% of the total variance. These results are similar to those of Tait et al. 18 According to the confirmatory factor analysis, the two-factor model fit was sufficient. Although concerns about the reliability of factor 2 (obligatory activities) are low, in our study, Cronbach's alpha of both factors (0.82 and 0.80) were sufficient, and, as expected, 24 all factor loadings were greater than 0.7.
Although the majority of our study participants' being females seems to be a limitation, rheumatic diseases have high female/male ratios. Therefore, the high female ratio of participants in the study sample might have contributed to the generalizability of our results as the study sample represents the population properly.
In the study of Biçer et al. 25 in Turkey, Cronbach's alpha of the PDI was found to be 0.84. However, our investigation is characterized by more reliable and generalizable results thanks to our larger sample size (212 participants in our study versus 83 in Biçer's study), higher item total correlation, and inclusion of a variety of musculoskeletal diseases that cause chronic pain; whereas in Biçer's study, the sample consisted of patients with low back pain. Furthermore, our use of exploratory and confirmatory factor analysis increased the strength of our results.
In conclusion, the Turkish version of the PDI had adequate psychometric properties in rheumatic patients with chronic pain, in terms of its internal consistency, test-retest reliability, convergent validity, and factorial structure. Thus, it may be useful in clinical practice to assist in better understanding of diseases characterized by chronic pain, providing objective measures for functional deficits, and monitoring treatment or rehabilitation effects. 
